glp-1 news today november 2025 Receptor Agonist Market Growth Analysis November in review: GLP-1 breakthroughs,

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions

mechanistic in-vitro findings are not human outcomes

HSP32/HO-1 suppresses the activation of pro-apoptotic JNK and prevents hair cell death

Dubai Health Authority (DHA) regulations require that IV therapy be administered by licensed healthcare professionals, and that the formulas used are pharmacy-prepared to clinical standards

The non-coded amino acid residues incorporated at positions 2, 20, and 13 provide resistance to enzymatic degradation while maintaining receptor-binding affinity across all three target receptors

Both of these new vaccines are still pending approval by the FDA